# SSAT063- Pharmacokinetics of Efavirenz 400 mg Once Daily During Pregnancy in HIV-1 Infected Women

> **NCT02499874** · PHASE1 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 26 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Efavirenz
- **DRUG:** tenofovir /emtricitabine
- **DRUG:** tenofovir/lamivudine
- **DRUG:** lamivudine/zidovudine

## Key facts

- **NCT ID:** NCT02499874
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2017-10-05
- **Final completion:** 2017-10-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02499874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02499874, "SSAT063- Pharmacokinetics of Efavirenz 400 mg Once Daily During Pregnancy in HIV-1 Infected Women". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02499874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*